Results 181 to 190 of about 33,329 (197)

Characterization of CD133 hepatocellular carcinoma cells as cancer stem/progenitor cells

Biochemical and Biophysical Research Communications, 2006
Tsutomu Motohashi, Hitomi Aoki, Atsushi Suetsugu   +2 more
exaly  

Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma

International Journal of Cancer, 2010
Zheng Zhu, Mingxia Yan, Jinjun Li
exaly  

Promoter hypomethylation regulates CD133 expression in human gliomas

Cell Research, 2008
Shinya Tanaka, Shinji Kohsaka, Kouichi Tabu   +2 more
exaly  

MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133+ Glioblastoma Stem Cells

Journal of Molecular Neuroscience, 2018
Zongmao Zhao, Zhongjie Yan
exaly  

Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer

Gastric Cancer, 2013
Keishiro Aoyagi, Taro Isobe
exaly  

CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133− cells

Laboratory Investigation, 2011
Celia Chao, Guillermo A. Gomez, Mark R Hellmich   +2 more
exaly  

Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody

Nanomedicine: Nanotechnology, Biology, and Medicine, 2011
Yu-Chih Chen, Ching-An Peng, Chen-Pin Chou   +2 more
exaly  

CD133+ niches and single cells in glioblastoma have different phenotypes

Journal of Neuro-Oncology, 2010
Henrik D Schrøder, Bjarne Winther Kristensen   +1 more
exaly  

CD133.

Journal of biological regulators and homeostatic agents, 2001
openaire   +1 more source

CD133 (prominin)

2008
openaire   +1 more source